{"DataElement":{"publicId":"3232342","version":"1","preferredName":"DNA In Situ Hybridization Probe Assessment Other Specify Text","preferredDefinition":"The free text field used to describe the name of the DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues.","longName":"DNA_ISH_PRB_AS_O_TXT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3232341","version":"1","preferredName":"DNA In situ Hybridization Probe Assessment","preferredDefinition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information._Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues_General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest. (On-line Medical Dictionary)_The final result of a determination of the value, significance, or extent of.","longName":"DNA_ISH_PROB_ASSESS","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2187556","version":"1","preferredName":"Deoxyribonucleic Acid","preferredDefinition":"A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).","longName":"DNA","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E1394212-B4FB-5819-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-09","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Changed long name ot EVS Preferred Name.  DW","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3232339","version":"1","preferredName":"in situ Hybridization Probe Assessment","preferredDefinition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues:General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest. (On-line Medical Dictionary):The final result of a determination of the value, significance, or extent of.","longName":"C17562:C43523:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ Hybridization","conceptCode":"C17562","definition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Probe","conceptCode":"C43523","definition":"General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will hybridize, a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1EB78F6-4C4B-2691-E040-BB89AD4315AA","latestVersionIndicator":"Yes","beginDate":"2011-04-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-04-27","modifiedBy":"ONEDATA","dateModified":"2011-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1EB78F6-4C5C-2691-E040-BB89AD4315AA","latestVersionIndicator":"Yes","beginDate":"2011-04-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-04-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2857322","version":"1","preferredName":"Other Specify Text","preferredDefinition":"The free text field that describes another response when other is chosen from a list of values.","longName":"OTHR_SPEC_TXT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2857047","version":"1","preferredName":"Other Specify Text","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C17649:C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"660AABE0-46ED-4890-E040-BB89AD431D5B","latestVersionIndicator":"Yes","beginDate":"2009-03-26","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-03-26","modifiedBy":"ONEDATA","dateModified":"2009-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6648A78E-AB33-047A-E040-BB89AD4324AB","latestVersionIndicator":"Yes","beginDate":"2009-03-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-03-29","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/22/17 tt transferred context, added registration status and CSI per Round 5 finalization task. Modified for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg (JP) 12/2010.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3232302","version":"1","longName":"In Situ Hybridization Biomarker Template","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other, specify","type":"Preferred Question Text","description":"Other, specify","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A1EB78F6-4C73-2691-E040-BB89AD4315AA","latestVersionIndicator":"Yes","beginDate":"2011-04-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-04-27","modifiedBy":"MAESKEB","dateModified":"2011-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}